cilengitide has been researched along with cediranib in 3 studies
Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (cediranib) | Trials (cediranib) | Recent Studies (post-2010) (cediranib) |
---|---|---|---|---|---|
194 | 29 | 133 | 279 | 102 | 204 |
Protein | Taxonomy | cilengitide (IC50) | cediranib (IC50) |
---|---|---|---|
Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.005 | |
Fibroblast growth factor receptor 1 | Homo sapiens (human) | 0.026 | |
Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.036 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.005 | |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.003 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0016 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stupp, R; Tabatabai, G | 1 |
Ahluwalia, MS; Batchelor, TT; Duda, DG; Gerstner, ER; Grossman, S; Jain, RK; Kaley, TJ; Levine, MA; Mikkelsen, T; Nabors, BL; Olson, JJ; Wen, PY; Ye, X | 1 |
Campian, JL; Chang, X; Fergus, S; Hallahan, D; Huang, J; Hui, C; Lin, AJ; Mullen, D; Rao, YJ; Rudra, S; Samson, P; Thotala, D; Tsien, C; Yang, D | 1 |
1 review(s) available for cilengitide and cediranib
Article | Year |
---|---|
[Angiogenesis inhibition in neurooncology. A very promising therapy strategy for malignant glioma].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Clinical Trials as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Glioma; Humans; Microcirculation; Neoplasm Recurrence, Local; Prognosis; Quinazolines; Snake Venoms; Vascular Endothelial Growth Factor A | 2010 |
1 trial(s) available for cilengitide and cediranib
Article | Year |
---|---|
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Glioblastoma; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Snake Venoms; Treatment Outcome; Young Adult | 2015 |
1 other study(ies) available for cilengitide and cediranib
Article | Year |
---|---|
Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bevacizumab; Carmustine; Chemoradiotherapy; Dasatinib; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Lymphocyte Count; Lymphopenia; Male; Middle Aged; Photons; Progression-Free Survival; Propensity Score; Quinazolines; Radiotherapy Dosage; Radiotherapy, Conformal; Snake Venoms; Supratentorial Neoplasms; Temozolomide; Young Adult | 2018 |